Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse
Creator
Kohara, Michinori
Tsukiyama-Kohara, Kyoko
Kai, Chieko
Satoh, Masaaki
Harada, Shinji
Iwanaga, Sumako
Okada, Seiji
Saito, Makoto
Seki, Takahiro
Tanaka, Kohsuke
Ali, Salem
Elwy, Salem
Source
Elsevier; Medline; PMC
abstract
Abstract In this study, we infected NOD/Scid/Jak3null mice engrafted human peripheral blood leukocytes (hu-PBL-NOJ) with measles virus Edmonston B strain (MV-Edm) expressing hepatitis C virus (HCV) envelope proteins (rMV-E1E2) to evaluate the immunogenicity as a vaccine candidate. Although human leukocytes could be isolated from the spleen of mock-infected mice during the 2-weeks experiment, the proportion of engrafted human leukocytes in mice infected with MV (103–105 pfu) or rMV-E1E2 (104 pfu) was decreased. Viral infection of the splenocytes was confirmed by the development of cytopathic effects (CPEs) in co-cultures of splenocytes and B95a cells and verified using RT-PCR. Finally, human antibodies against MV were more frequently observed than E2-specific antibodies in serum from mice infected with a low dose of virus (MV, 100–101 pfu, and rMV-E1E2, 101–102 pfu). These results showed the possibility of hu-PBL-NOJ mice for the evaluation of the immunogenicity of viral proteins.
has issue date
2010-12-31
(
xsd:dateTime
)
bibo:doi
10.1016/j.cimid.2010.02.006
bibo:pmid
20299097
has license
els-covid
sha1sum (hex)
071017f2154249040bf73e9e5940b54d49221e1b
schema:url
https://doi.org/10.1016/j.cimid.2010.02.006
resource representing a document's title
Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse
has PubMed Central identifier
PMC7112578
has PubMed identifier
20299097
schema:publication
Comparative Immunology, Microbiology and Infectious Diseases
resource representing a document's body
covid:071017f2154249040bf73e9e5940b54d49221e1b#body_text
is
schema:about
of
named entity 'Edmonston'
named entity 'isolated'
named entity 'pfu'
named entity 'proportion'
named entity 'measles virus'
named entity 'expressing'
named entity 'LOW DOSE'
named entity 'VIRUS'
named entity 'DECREASED'
named entity 'NOD'
named entity 'COCULTURES'
named entity 'ANTIBODIES'
named entity 'B95A'
named entity 'MICE'
named entity 'EXPERIMENT'
named entity 'SPLENOCYTES'
named entity 'LEUKOCYTES'
named entity 'VACCINE CANDIDATE'
named entity 'VERIFIED'
named entity 'INFECTION'
named entity 'NOD'
named entity 'PROTEINS'
named entity 'EDM'
named entity 'DEVELOPMENT'
named entity 'INFECTED'
named entity 'HUMAN'
named entity 'PBL'
named entity 'EVALUATION'
named entity 'MEASLES VIRUS'
named entity 'MOUSE'
named entity 'PFU'
named entity 'EVALUATE'
named entity 'FREQUENTLY'
named entity 'BLOOD LEUKOCYTES'
named entity 'STRAIN'
named entity 'IMMUNOGENICITY'
named entity 'SERUM'
named entity 'CELLS'
named entity 'OBSERVED'
named entity 'MEASLES VIRUS'
named entity 'RESULTS'
named entity 'EVALUATION'
named entity 'MOCK'
named entity 'VIRUS ENVELOPE PROTEINS'
named entity 'SPLEEN'
named entity 'HEPATITIS C VIRUS'
named entity 'USING'
named entity 'COULD BE'
named entity 'CONFIRMED BY'
named entity 'SPECIFIC'
named entity 'ISOLATED'
named entity 'VIRAL INFECTION'
named entity 'PROPORTION'
named entity 'ENVELOPE'
named entity 'VIRAL PROTEINS'
named entity 'RECOMBINANT'
named entity 'RT-PCR'
named entity 'THESE'
named entity 'HEPATITIS C VIRUS'
named entity 'STUDY'
named entity 'PERIPHERAL BLOOD'
named entity 'HUMAN'
named entity 'CYTOPATHIC EFFECTS'
named entity 'PBL'
named entity 'WEEKS'
covid:arg/071017f2154249040bf73e9e5940b54d49221e1b
named entity 'HCV'
named entity 'Viral infection'
named entity 'development'
named entity 'human'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software